-
1
-
-
0028881591
-
Management of refractory ankylosing spondylitis and related spondylarthropathies
-
Amor B, Dougados M, Khan MA. Management of refractory ankylosing spondylitis and related spondylarthropathies. Rheum Dis Clin North Am 1995; 21: 117-128
-
(1995)
Rheum Dis Clin North Am
, vol.21
, pp. 117-128
-
-
Amor, B.1
Dougados, M.2
Khan, M.A.3
-
3
-
-
0036558995
-
Confidence in the diagnosis of early spondylarthropathy
-
Berthelot JM, Saraux A, Le Henaff C et al. Confidence in the diagnosis of early spondylarthropathy. Clin Exp Rheumatol 2002; 20: 319-326
-
(2002)
Clin Exp Rheumatol
, vol.20
, pp. 319-326
-
-
Berthelot, J.M.1
Saraux, A.2
Le Henaff, C.3
-
4
-
-
0242526924
-
Die Akzeptanz des Schulungsprogramms der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien
-
Bönisch A, Ehlebracht-Kömg I. Die Akzeptanz des Schulungsprogramms der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien. Akt Rheumatol 2003; 28: 254-263
-
(2003)
Akt Rheumatol
, vol.28
, pp. 254-263
-
-
Bönisch, A.1
Ehlebracht-Kömg, I.2
-
5
-
-
0032726541
-
Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging
-
Brandt J, Bollow M, Haberle J et al. Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging. Rheumatology 1999; 38: 831-836
-
(1999)
Rheumatology
, vol.38
, pp. 831-836
-
-
Brandt, J.1
Bollow, M.2
Haberle, J.3
-
6
-
-
0037783485
-
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
-
Brandt J, Khariouzov A, Listing J et al. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003; 48: 1667-1675
-
(2003)
Arthritis Rheum
, vol.48
, pp. 1667-1675
-
-
Brandt, J.1
Khariouzov, A.2
Listing, J.3
-
7
-
-
0029926665
-
Computed tomography guided injection of sacroiliac joint in patients with spondylarthropathy with sacroiliitis
-
Braun J et al. Computed tomography guided injection of sacroiliac joint in patients with spondylarthropathy with sacroiliitis. J Rheumatol 1996; 23: 659-664
-
(1996)
J Rheumatol
, vol.23
, pp. 659-664
-
-
Braun, J.1
-
8
-
-
0031972623
-
Prevalence of spondylarthropathies in HLA-B27 positive and negative mood donors
-
Braun J, Bollow M, Remlinger C et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative mood donors. Arthritis Rheum 1998; 41: 58-67
-
(1998)
Arthritis Rheum
, vol.41
, pp. 58-67
-
-
Braun, J.1
Bollow, M.2
Remlinger, C.3
-
10
-
-
0034998665
-
Therapie der ankylosierenden Spondylitis mit Radiumchlorid
-
Braun J, Lemmel EM, Manger B, Rau R, Sörensen H, Sieper J. Therapie der ankylosierenden Spondylitis mit Radiumchlorid. Z Rheumatol 2001; 60: 74-83
-
(2001)
Z Rheumatol
, vol.60
, pp. 74-83
-
-
Braun, J.1
Lemmel, E.M.2
Manger, B.3
Rau, R.4
Sörensen, H.5
Sieper, J.6
-
11
-
-
0037029430
-
Treatment of active ankylosing spondylitis with infliximab: A randomised controlled multicentre trial
-
Braun J, Brandt J, Listing J et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002; 359: 1187-1193
-
(2002)
Lancet
, vol.359
, pp. 1187-1193
-
-
Braun, J.1
Brandt, J.2
Listing, J.3
-
12
-
-
0038423033
-
International ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
-
Braun J, Pham T, Sieper J, van der Linden S, Dougados M, van der Heijde D for the ASAS working group. International ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis 2003; 62: 817-824
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 817-824
-
-
Braun, J.1
Pham, T.2
Sieper, J.3
Van Der Linden, S.4
Dougados, M.5
Van Der Heijde, D.6
-
13
-
-
0042072982
-
Long term efficacy and safety of infliximab in the treatment of ankylosing spondylitis
-
Braun J, Brandt J, Listing J et al. Long term efficacy and safety of infliximab in the treatment of ankylosing spondylitis. Arthritis Rheum 2003; 48: 2224-2233
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2224-2233
-
-
Braun, J.1
Brandt, J.2
Listing, J.3
-
14
-
-
0033511186
-
Comparison of sulphasalazine and placebo for the treatment of axial and peripheral articular manifestations of seronegative spondylarthropathies
-
Clegg DO, Reda DJ, Abdellatif M. Comparison of sulphasalazine and placebo for the treatment of axial and peripheral articular manifestations of seronegative spondylarthropathies. Arthritis Rheum 1999; 42: 2325-2329
-
(1999)
Arthritis Rheum
, vol.42
, pp. 2325-2329
-
-
Clegg, D.O.1
Reda, D.J.2
Abdellatif, M.3
-
15
-
-
0034538715
-
Can some cases of 'possible' Spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy?
-
Collantes E, Veroz R, Escudero A the Spanish Spondyloarthropathy Study Group. Can some cases of 'possible' Spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Joint Bone Spine 2000; 67: 516-520
-
(2000)
Joint Bone Spine
, vol.67
, pp. 516-520
-
-
Collantes, E.1
Veroz, R.2
Escudero, A.3
-
16
-
-
0026003027
-
Preliminary criteria for the classification of spondylarthropathy
-
The European Spondylarthropathy Study Group
-
Dougados M, van der Linden SM, Jhulin R et al. The European Spondylarthropathy Study Group. Preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-1227
-
(1991)
Arthritis Rheum
, vol.34
, pp. 1218-1227
-
-
Dougados, M.1
Van Der Linden, S.M.2
Jhulin, R.3
-
18
-
-
0035150435
-
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis
-
Dougados M, Behier JM, Jolcine I et al. Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis. Arthritis Rheum 2001; 44: 80-85
-
(2001)
Arthritis Rheum
, vol.44
, pp. 80-85
-
-
Dougados, M.1
Behier, J.M.2
Jolcine, I.3
-
19
-
-
84862356254
-
Bewertung eines Schulungsprogramms für Patienten mit Spondylitis ankylosans
-
Ehlebracht-König I. Bewertung eines Schulungsprogramms für Patienten mit Spondylitis ankylosans. Bechterew-Brief 2003; 92: 3-12
-
(2003)
Bechterew-Brief
, vol.92
, pp. 3-12
-
-
Ehlebracht-König, I.1
-
20
-
-
0242443383
-
Das Schulungsprogramm der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien - Programmaufbau
-
Ehlebracht-König I, Bönisch A. Das Schulungsprogramm der DGRh für Patienten mit Spondylitis ankylosans und verwandten Spondylarthropathien - Programmaufbau. Akt Rheumatol 2003; 28: 243-253
-
(2003)
Akt Rheumatol
, vol.28
, pp. 243-253
-
-
Ehlebracht-König, I.1
Bönisch, A.2
-
21
-
-
0028575453
-
A new approach to defining disease status in ankylosing spondylitis
-
Garrett S, Jenkinson T, Kennedy LG et al. A new approach to defining disease status in ankylosing spondylitis. J Rheumatol 1994; 21: 2286-2291
-
(1994)
J Rheumatol
, vol.21
, pp. 2286-2291
-
-
Garrett, S.1
Jenkinson, T.2
Kennedy, L.G.3
-
22
-
-
0037007683
-
Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha
-
Gorman JD, Sack KE, Jr. Davis JC. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002; 346: 1349-1356
-
(2002)
N Engl J Med
, vol.346
, pp. 1349-1356
-
-
Gorman, J.D.1
Sack Jr., K.E.2
Davis, J.C.3
-
24
-
-
0027296402
-
The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years
-
Kirwan J, Edwards A, Huitfeldt B, Thompson P, Currey H. The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years. Br J Rheumatol 1993; 32: 729-733
-
(1993)
Br J Rheumatol
, vol.32
, pp. 729-733
-
-
Kirwan, J.1
Edwards, A.2
Huitfeldt, B.3
Thompson, P.4
Currey, H.5
-
26
-
-
0141560728
-
Rational for the use of Cyclooxygenase-2 specific nonsteroidal antiinflammatory drugs in ankylosing spondylitis - Which evidences are available?
-
Koehler L, Kuipers JG, Zeidler H. Rational for the use of Cyclooxygenase-2 specific nonsteroidal antiinflammatory drugs in ankylosing spondylitis - Which evidences are available? Curr Rheumatol Rep 2003; 5: 178-180
-
(2003)
Curr Rheumatol Rep
, vol.5
, pp. 178-180
-
-
Koehler, L.1
Kuipers, J.G.2
Zeidler, H.3
-
27
-
-
0034890083
-
Long-term outcome of undifferentiated spondylarthropathy
-
Kumar A, Bansal M, Srivastava DN et al. Long-term outcome of undifferentiated spondylarthropathy. Rheumatol Intern 2001; 20: 221-224
-
(2001)
Rheumatol Intern
, vol.20
, pp. 221-224
-
-
Kumar, A.1
Bansal, M.2
Srivastava, D.N.3
-
28
-
-
0029617257
-
Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up
-
Lethinen A, Leirisalo-Repo M, Taavitsainen M. Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up. Clin Exp Rheumatol 1995; 13: 733-736
-
(1995)
Clin Exp Rheumatol
, vol.13
, pp. 733-736
-
-
Lethinen, A.1
Leirisalo-Repo, M.2
Taavitsainen, M.3
-
29
-
-
0036188770
-
A six-month randomized, controlled, double-blinded, dose response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of NSAID-refractory ankylosing spondylitis
-
Maksymowych WP, Jhangri GS, Fitzgerald A et al. A six-month randomized, controlled, double-blinded, dose response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of NSAID-refractory ankylosing spondylitis. Arthritis Rheum 2002; 46: 766-782
-
(2002)
Arthritis Rheum
, vol.46
, pp. 766-782
-
-
Maksymowych, W.P.1
Jhangri, G.S.2
Fitzgerald, A.3
-
30
-
-
0035459313
-
Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy
-
Marzo-Ortega H et al. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy. Arthritis Rheum 2001; 44: 2112-2117
-
(2001)
Arthritis Rheum
, vol.44
, pp. 2112-2117
-
-
Marzo-Ortega, H.1
-
31
-
-
0023719950
-
Clinical features and prognosis of patients with possible ankylosing spondylitis
-
Mau W, Zeidler H, Mau R et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. J Rheumatol 1988; 15: 1109-1114
-
(1988)
J Rheumatol
, vol.15
, pp. 1109-1114
-
-
Mau, W.1
Zeidler, H.2
Mau, R.3
-
32
-
-
0029765115
-
Assessment of the efficacy of sacroiliac corticoid injections in spondylarthropathies
-
Maugars Y, Mathis C et al. Assessment of the efficacy of sacroiliac corticoid injections in spondylarthropathies. Br J Rheumatol 1996; 35: 767-770
-
(1996)
Br J Rheumatol
, vol.35
, pp. 767-770
-
-
Maugars, Y.1
Mathis, C.2
-
33
-
-
0031765693
-
Enthesiopathy: Clinical manifestations, imaging and treatment
-
Olivieri I, Barozzi L, Padula A. Enthesiopathy: clinical manifestations, imaging and treatment. Baillieres Clin Rheumatol 1998; 12: 665-681
-
(1998)
Baillieres Clin Rheumatol
, vol.12
, pp. 665-681
-
-
Olivieri, I.1
Barozzi, L.2
Padula, A.3
-
34
-
-
0034840543
-
Ankylosing spondylitis and undifferentiated spondyloarthropathies
-
Olivieri I, Salvarani C, Cantine F et al. Ankylosing spondylitis and undifferentiated spondyloarthropathies. Curr Opin Rheumatol 2001; 13: 280-284
-
(2001)
Curr Opin Rheumatol
, vol.13
, pp. 280-284
-
-
Olivieri, I.1
Salvarani, C.2
Cantine, F.3
-
37
-
-
0001736719
-
Spondylitis ankylopoetica:Die so genannte Bechterewsche Krankheit und ihre Differentialdiagnose
-
Berlin, Heidelberg, New York, Tokio, Springer, Diethelm L (Hrsg)
-
Schilling F. Spondylitis ankylopoetica:Die so genannte Bechterewsche Krankheit und ihre Differentialdiagnose. Berlin, Heidelberg, New York, Tokio, Springer, In: Diethelm L (Hrsg) Handbuch der medizinischen Radiologie. 1974: 452-689
-
(1974)
Handbuch der Medizinischen Radiologie
, pp. 452-689
-
-
Schilling, F.1
-
38
-
-
0036226095
-
Sulfasalazin bei Sp. a
-
Schmidt WA, Wierth S, Milleck D, Droste U, Gromnica-Ihle E. Sulfasalazin bei Sp. a.: Z Rheumatol 2002; 61: 159-169
-
(2002)
Z Rheumatol
, vol.61
, pp. 159-169
-
-
Schmidt, W.A.1
Wierth, S.2
Milleck, D.3
Droste, U.4
Gromnica-Ihle, E.5
-
39
-
-
0032915527
-
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis
-
Spoorenberg A, van der Heijde D, de Klerk E et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999; 26: 980-984
-
(1999)
J Rheumatol
, vol.26
, pp. 980-984
-
-
Spoorenberg, A.1
Van Der Heijde, D.2
De Klerk, E.3
-
40
-
-
0031818027
-
Current guidelines for drug treatment of ankylosing spondylitis
-
Toussirot E, Wendling D. Current guidelines for drug treatment of ankylosing spondylitis. Drugs 1998; 5: 225-240
-
(1998)
Drugs
, vol.5
, pp. 225-240
-
-
Toussirot, E.1
Wendling, D.2
-
41
-
-
0029616525
-
Inflammatory back pain in primary care
-
Underwood MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol 1995; 34: 1074-1077
-
(1995)
Br J Rheumatol
, vol.34
, pp. 1074-1077
-
-
Underwood, M.R.1
Dawes, P.2
-
42
-
-
0036188187
-
Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy
-
van den Bosch F, Kruithof E, Baeten D et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum 2002; 46: 755-765
-
(2002)
Arthritis Rheum
, vol.46
, pp. 755-765
-
-
Van Den Bosch, F.1
Kruithof, E.2
Baeten, D.3
-
44
-
-
0034758237
-
Combined spa-exercise therapy is effective in patients with ankylosing spondylitis
-
van Tubergen A et al. Combined spa-exercise therapy is effective in patients with ankylosing spondylitis. Arthritis Rheum 2001; 45: 430-438
-
(2001)
Arthritis Rheum
, vol.45
, pp. 430-438
-
-
Van Tubergen, A.1
-
45
-
-
0037109238
-
Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis
-
van Tubergen A, Boonen A, Landewe R et al. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis. Arthritis Rheum 2002; 47: 459-467
-
(2002)
Arthritis Rheum
, vol.47
, pp. 459-467
-
-
Van Tubergen, A.1
Boonen, A.2
Landewe, R.3
-
46
-
-
1642472317
-
Inhibition of radiographic progression in ankylosing spondylitis (AS) by continuous use of NSAIDS
-
Wanders A. Inhibition of radiographic progression in ankylosing spondylitis (AS) by continuous use of NSAIDS. Arthritis Rheum 2003; 48 (Suppl): S 233
-
(2003)
Arthritis Rheum
, vol.48
, Issue.SUPPL.
-
-
Wanders, A.1
-
48
-
-
0034020245
-
Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - Results from the German rheumatological database
-
German Collaborative Arthritis Centers
-
Zink A, Braun J, Listin J, Wollenhaupt J. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis - results from the German rheumatological database. German Collaborative Arthritis Centers. J Rheumatol 2000; 27: 613-622
-
(2000)
J Rheumatol
, vol.27
, pp. 613-622
-
-
Zink, A.1
Braun, J.2
Listin, J.3
Wollenhaupt, J.4
-
49
-
-
4244054230
-
Local radiotherapy for painful heels with spondarthropathies
-
2nd edn (Hrsg). London, Mosby, Klippel JH, Dieppe PA (eds.).
-
Zvaifler NJ, Seagren SL. Local radiotherapy for painful heels with spondarthropathies. 2nd edn (Hrsg). London, Mosby, In: Klippel JH, Dieppe PA (eds.). Rheumatology. 1998; Vol 2: 20.7-20.8.
-
(1998)
Rheumatology
, vol.2
, pp. 207-208
-
-
Zvaifler, N.J.1
Seagren, S.L.2
|